Dokumentuaren aipamena
APA (7th ed.) Zitazioa
Onur, İ. D., Kınıkoğlu, O., Kavgacı, G., Kuzu, Ö. F., Başoğlu, T., Ateş, Ö., & Karaçin, C. (2025). Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period. Ankara Hematology Oncology Association.
Ondo kopiatu da
Kopiatzeak huts egin du
Chicago Style (17th ed.) Zitazioa
Onur, İlknur Deliktaş, Oğuzcan Kınıkoğlu, Gözde Kavgacı, Ömer Faruk Kuzu, Tuğba Başoğlu, Öztürk Ateş, eta Cengiz Karaçin. Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period. Ankara Hematology Oncology Association, 2025.
Ondo kopiatu da
Kopiatzeak huts egin du
MLA (9th ed.) Zitazioa
Onur, İlknur Deliktaş, et al. Evaluation of the Effect of Radiotherapy Timing on Toxicity in HER2-Positive Breast Cancer Receiving Trastuzumab Emtansine During the Adjuvant Period. Ankara Hematology Oncology Association, 2025.
Ondo kopiatu da
Kopiatzeak huts egin du
Kontuz: berrikusi erreferentzia hauek erabili aurretik.